Wednesday, November 30, 2022 3:10:57 PM
The thing that strikes me as somewhat comical is the naivete' of these doctors and their financiers that must believe that their opinions really have an effect on THE APPROVAL PROCESS !!!"Come on, Man!!!" The RA's of the world have at their side, the world's greatest medical authority on the planet, the JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. Further, and this is what is really shocking to the credibility of these 9 doctors and that is these 9 doctors must believe that before JAMA published the article, the entire team of experts hadn't considered ,"IN DEPTH", the comments/questions they are making/asking and determined that they were not only answered , but confirmed that they had no adverse effect on the statistically significant and meaningfully overall, positive results of the Phase 3 trial for DCVax-L and how that effects the worldwide RA approval process!!
One thing's for sure and is an absolute fact and that is, nowhere in the credentials of the 9 doctors is it reflected that they work with Dr. Ashkan and his team at Kings College or were part of the expert team of 50 doctors that rigorously, peer reviewed the Phase 3 trial for the Journal of the American Medical Association ( JAMA) or were part of the 70 lead investigators/expert doctors for the trial or in any way part of any organization or association that would lend credibility or standing to any of the statements they are making!!! AND further, were unfamiliar with the trial results until they read the JAMA article and were provided an analysis of the article by a journalist!!
The most important fact that is "front page, above the fold" for the world's patient population and the healthcare world and to the world as a whole is that DCVax-L immunotherapy vaccine IS THE FIRST TREATMENT FOR nGBM and rGBM IN OVER 30 YEARS THAT HAS IMPROVED OVERALL SURVIVAL AND VASTLY EXTENDS LIFE EXPECTANCY By all measures that is proven by the medical community and that is what counts, not a few comments from 9 unknown doctors trying to split hairs on obscure and irrelevant parts of the trial process!!
As a final "PROOF OF CONCEPT", I refer you to the JAMA publication and specifically, the 18 minute interview with Dr. Linda Liau located on the top of the page at the media button.
And finally, I've tried to resist from making this comment, because it might be interpreted as I'm giving way to emotionalism, but here it is:
" Why would anyone believe anything that the world of money grubbing traders have to say about any medical treatment for deadly diseases that is offered with the ultimate goal of providing PROMISE and HOPE in the efforts to save lives"????? AND instead, believe those traders whose intent is to delay and deny the desperately needed patient treatments, for the sake of money!!
Let's hope that our world is not so deep into political and financial considerations, that we have lost touch with the needs of patients!!!
Cheers,
BB
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM